Biocon Releases Q2 2026 Financial Results; Group Revenue Reaches 43,360 Million
Biocon Limited has announced its unaudited financial results for the quarter ended June 30, 2026. The company's Board of Directors approved both the standalone and consolidated results, which were limitedly reviewed by statutory auditors.The consolidated figures showed a total income of 43,905 million in the quarter, with revenue derived from operations standing at 43,360 million. Net profit for the period stood at 1,368 million, while the total comprehensive income was reported at 9,256 million.The standalone entity reported a revenue from operations of 6,245 million. Total income reached 6,893 million, before accounting for total expenses of 6,194...